Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2017-02-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.6b01227PMID 28118010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Journal of Medicinal Chemistry, Technological Advances: Highlights 2015-2016.

  2017cited by this paper
• Anti-Influenza Treatment: Drugs Currently Used and Under Development.

  2017cited by this paper
• Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H.

  2016cited by this paper
• A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro

  2016cited by this paper
• 3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.

  2016cited by this paper
• Antiviral therapies on the horizon for influenza.

  2016cited by this paper
• New Insight into Metal Ion-Driven Catalysis of Nucleic Acids by Influenza PA-Nter

  2016cited by this paper
• Current and novel antiviral strategies for influenza infection.

  2016cited by this paper
• Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries.

  2016cited by this paper
• Discovery of novel 5-hydroxy-4-pyridone-3-carboxy acids as potent inhibitors of influenza Cap-dependent endonuclease.

  2016cited by this paper
• N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes

  2016cited by this paper
• Tratamiento antigripal: fármacos actualmente utilizados y nuevos agentes en desarrollo

  2016cited by this paper
• 3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.

  2016cited by this paper
• Two Distinctive Binding Modes of Endonuclease Inhibitors to the N-Terminal Region of Influenza Virus Polymerase Acidic Subunit.

  2016cited by this paper
• Fragment-Based Identification of Influenza Endonuclease Inhibitors

  2016cited by this paper
• Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor

  2016cited by this paper
• The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design

  2016cited by this paper
• A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase

  2016cited by this paper
• Novel indole–flutimide heterocycles with activity against influenza PA endonuclease and hepatitis C virus

  2016cited by this paper
• Identification of a Novel Complex between the Nucleoprotein and PA(1-27) of Influenza A Virus Polymerase.

  2016cited by this paper
• Beware of docking!

  2015cited by this paper
• Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase.

  2015cited by this paper
• An Integrated Biological Approach to Guide the Development of Metal-Chelating Inhibitors of Influenza Virus PA Endonuclease

  2015cited by this paper
• Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease

  2015cited by this paper
• 8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential

  2015cited by this paper
• Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators.

  2015cited by this paper
• Repurposing of HDAC inhibitors toward anti-hepatitis C virus drug discovery: teaching an old dog new tricks.

  2015cited by this paper
• Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza

  2015cited by this paper
• Clinical Implications of Antiviral Resistance in Influenza

  2015cited by this paper
• Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities

  2015cited by this paper
• Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors.

  2015cited by this paper
• Computation-guided discovery of influenza endonuclease inhibitors.

  2014cited by this paper
• Recent advances in the structure-based rational design of TNKSIs.

  2014cited by this paper
• DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.

  2014cited by this paper
• From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?

  2014cited by this paper
• Structural insight into cap-snatching and RNA synthesis by influenza polymerase

  2014cited by this paper
• Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011 – 2014)

  2014cited by this paper
• Exploring the Influence of the Protein Environment on Metal-Binding Pharmacophores

  2014cited by this paper
• Docking Ligands into Flexible and Solvated Macromolecules. 6. Development and Application to the Docking of HDACs and other Zinc Metalloenzymes Inhibitors

  2014cited by this paper
• Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities

  2014cited by this paper
• Easily Accessible Polycyclic Amines that Inhibit the Wild-Type and Amantadine-Resistant Mutants of the M2 Channel of Influenza A Virus

  2014cited by this paper
• "Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets.

  2014cited by this paper
• Magnesium-dependent RNA binding to the PA endonuclease domain of the avian influenza polymerase.

  2014cited by this paper
• Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate.

  2014cited by this paper
• Antiviral combinations for severe influenza

  2014cited by this paper
• Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery.

  2014cited by this paper
• "Old friends in new guise": exploiting privileged structures for scaffold re-evolution/refining.

  2014cited by this paper
• Structure of influenza A polymerase bound to the viral RNA promoter

  2014cited by this paper
• Metal-chelating 2-hydroxyphenyl amide pharmacophore for inhibition of influenza virus endonuclease.

  2014cited by this paper
• Phenyl Substituted 4-Hydroxypyridazin-3(2H)-ones and 5-Hydroxypyrimidin-4(3H)-ones: Inhibitors of Influenza A Endonuclease

  2014cited by this paper
• The N-Terminal Domain of PA from Bat-Derived Influenza-Like Virus H17N10 Has Endonuclease Activity

  2013cited by this paper
• Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site.

  2013cited by this paper
• Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors.

  2013cited by this paper
• Mutational Analysis of the Binding Pockets of the Diketo Acid Inhibitor L-742,001 in the Influenza Virus PA Endonuclease

  2013cited by this paper
• Favipiravir (T-705), a novel viral RNA polymerase inhibitor.

  2013cited by this paper
• 3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease.

  2013cited by this paper
• Phenyl substituted 3-hydroxypyridin-2(1H)-ones: inhibitors of influenza A endonuclease.

  2013cited by this paper
• Recent progress in structure-based anti-influenza drug design.

  2012cited by this paper
• Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.

  2012cited by this paper
• Fragment screening using X-ray crystallography.

  2012cited by this paper
• Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease

  2012cited by this paper
• Structural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) Polymerase

  2012cited by this paper
• Structure-guided discovery of phenyl-diketo acids as potent inhibitors of M. tuberculosis malate synthase.

  2012cited by this paper
• Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

  2011cited by this paper
• Binding mode prediction and inhibitor design of anti-influenza virus diketo acids targeting metalloenzyme RNA polymerase by molecular docking

  2011cited by this paper
• Anti-Influenza Activity of Marchantins, Macrocyclic Bisbibenzyls Contained in Liverworts

  2011cited by this paper
• Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.

  2011cited by this paper
• Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide.

  2010cited by this paper
• Current Trends in Ligand-Based Virtual Screening: Molecular Representations, Data Mining Methods, New Application Areas, and Performance Evaluation

  2010cited by this paper
• Influenza A Virus Polymerase: Structural Insights into Replication and Host Adaptation Mechanisms*

  2010cited by this paper
• Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription

  2010cited by this paper
• Structures of influenza A proteins and insights into antiviral drug targets

  2010cited by this paper
• Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase

  2009cited by this paper
• Global transmission of oseltamivir-resistant influenza.

  2009cited by this paper
• Nucleoside Monophosphate Complex Structures of the Endonuclease Domain from the Influenza Virus Polymerase PA Subunit Reveal the Substrate Binding Site inside the Catalytic Center

  2009cited by this paper
• Design strategies of novel NNRTIs to overcome drug resistance.

  2009cited by this paper
• Structure-function studies of the influenza virus RNA polymerase PA subunit

  2009cited by this paper
• Severe respiratory disease concurrent with the circulation of H1N1 influenza.

  2009cited by this paper
• Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site

  2009cited by this paper
• RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.

  2009cited by this paper
• The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit

  2009cited by this paper
• Crystal structure of the polymerase PAC–PB1N complex from an avian influenza H5N1 virus

  2008cited by this paper
• Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

  2008cited by this paper
• Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.

  2008cited by this paper
• Scientific barriers to developing vaccines against avian influenza viruses

  2007cited by this paper
• The influence of drug-like concepts on decision-making in medicinal chemistry

  2007cited by this paper
• Fragment-based screening using X-ray crystallography and NMR spectroscopy.

  2007cited by this paper
• Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention

  2007cited by this paper
• Vaccines for seasonal and pandemic influenza.

  2006cited by this paper
• Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

  2006cited by this paper
• Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.

  2005cited by this paper
• Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.

  2005cited by this paper
• Antiviral effect of catechins in green tea on influenza virus.

  2005cited by this paper
• Bioisosterism: a useful strategy for molecular modification and drug design.

  2005cited by this paper
• β-Diketo Acid Pharmacophore Hypothesis. 1. Discovery of a Novel Class of HIV-1 Integrase Inhibitors

  2005cited by this paper
• Virtual screening against metalloenzymes for inhibitors and substrates.

  2005cited by this paper
• Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.

  2005cited by this paper
• Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors.

  2003cited by this paper
• The treatment of influenza with antiviral drugs.

  2003cited by this paper
• Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors.

  2003cited by this paper

• Nucleoside antiviral agents with atypical structures and new targets.

  2025cites this paper
• Design and Development of Small‐Molecule Drugs Targeting Enzymes Utilizing Two‐Metal‐Ion Catalytic Mechanisms

  2025cites this paper
• Privileged scaffold repurposed: the evolving role of quinolone derivatives in antiviral therapy.

  2025cites this paper
• Discovery of a Baloxavir‐Inspired Endonuclease Inhibitor That Prevents Herpes Simplex Virus 1 Replication in Cell Culture and In Vivo

  2025cites this paper
• Design and Synthesis of PAN Endonuclease Inhibitors through Spirocyclization Strategy against Influenza A Virus.

  2025cites this paper
• Podands with phthalimide and dihydro(azolo)pyrimidine or pyrazolopyridine moieties, their cytotoxicity and antiviral activity

  2025cites this paper
• Beyond natural flavonoids: exploring bioisosterism in design and synthesis of influenza endonuclease inhibitors

  2025cites this paper
• Design, synthesis, and activity evaluation of C-8 arylated luteolin derivatives as influenza endonuclease inhibitors.

  2025cites this paper
• Optimization and biological evaluation of l-DOPA derivatives as potent influenza PAN endonuclease inhibitors with multi-site binding characteristics.

  2024cites this paper
• Hydroformylation and Late-Stage Diversification on Densely Functionalized Cores of Influenza Endonuclease Inhibitors

  2024cites this paper
• Design and synthesis of 7-membered lactam fused hydroxypyridinones as potent metal binding pharmacophores (MBPs) for inhibiting influenza virus PAN endonuclease.

  2024cites this paper
• Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways.

  2024cites this paper
• Outlining recent updates on influenza therapeutics and vaccines: A comprehensive review

  2024cites this paper
• Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery.

  2024cites this paper
• Medicinal chemistry strategies in the discovery and optimization of HBV core protein allosteric modulators (2018–2022 update)

  2023cites this paper
• Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality

  2023cites this paper
• Rational design and optimization of acylthioureas as novel potent influenza virus non-nucleoside polymerase inhibitors.

  2023cites this paper
• Targeting Ribonucleases with Small Molecules and Bifunctional Molecules

  2023cites this paper
• RNA Overwriting of Cellular mRNA by Cas13b-Directed RNA-Dependent RNA Polymerase of Influenza A Virus

  2023cites this paper
• Respiratory Syncytial Virus Infection: Treatments and Clinical Management

  2023cites this paper
• Multi-Target Approaches of Epigallocatechin-3-O-gallate (EGCG) and its Derivatives Against Influenza Viruses.

  2022cites this paper
• Identification of N- and C-3-Modified Laudanosoline Derivatives as Novel Influenza PAN Endonuclease Inhibitors.

  2022cites this paper
• CURRENT INNOVATION IN ANTI-HIV DRUG DISCOVERY AND PRODUCT DEVELOPMENT: A REVIEW

  2022influential citation
• Structural and Biochemical Basis for Development of Diketo Acid Inhibitors Targeting the Cap-Snatching Endonuclease of the Ebinur Lake Virus (Order: Bunyavirales)

  2022cites this paper
• Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit.

  2022cites this paper
• Computational Prediction of the Binding Pose of Metal-Binding Pharmacophores.

  2022cites this paper
• Design, synthesis, and biological activity of a novel series of 2-ureidonicotinamide derivatives against influenza A virus.

  2022cites this paper
• Discovery of Aryl Benzoyl Hydrazide Derivatives as Novel Potent Broad-Spectrum Inhibitors of Influenza A Virus RNA-Dependent RNA Polymerase (RdRp).

  2022cites this paper
• RNA Editing with Viral RNA-Dependent RNA Polymerase.

  2022cites this paper
• Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.

  2021cites this paper
• Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents.

  2021cites this paper
• Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses.

  2021cites this paper
• Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment

  2021cites this paper
• The Design and Application of Bioisosteres in Drug Design

  2021cites this paper
• Synthesis and In Vitro Evaluation of C-7 and C-8 Luteolin Derivatives as Influenza Endonuclease Inhibitors

  2021cites this paper
• HIV-1 and HBV RNase H as Metal-Chelating Inhibitors: Discovery and Medicinal Chemistry Strategies

  2021cites this paper
• Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors.

  2021cites this paper
• Identification of Influenza PAN Endonuclease Inhibitors via 3D-QSAR Modeling and Docking-Based Virtual Screening

  2021cites this paper
• Baloxavir Marboxil: An Original New Drug against Influenza

  2021cites this paper
• The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral Target

  2020cites this paper
• Recent Developments in Small Molecular HIV‐1 and Hepatitis B Virus RNase H Inhibitors

  2020cites this paper
• Design, Synthesis, and Biological Evaluation of Novel Acylhydrazone Derivatives as Potent Neuraminidase Inhibitors.

  2020cites this paper
• Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.

  2020cites this paper
• Thiosemicarbazides: Updates on antivirals strategy.

  2020cites this paper
• Design, synthesis and in vitro anti-influenza A virus evaluation of novel quinazoline derivatives containing S-acetamide and NH-acetamide moieties at C-4.

  2020cites this paper
• Non-rigid Diarylmethyl Analogs of Baloxavir as CAP-Dependent Endonuclease Inhibitors of Influenza Viruses.

  2020cites this paper
• Oseltamivir analogs with potent anti-influenza virus activity.

  2020cites this paper
• Medicinal chemistry insights into novel CDC25 inhibitors.

  2020cites this paper
• Design, synthesis and anti-influenza A virus activity of novel 2,4-disubstituted quinazoline derivatives.

  2020cites this paper
• Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development.

  2019influential citation
• Concise, stereocontrolled and modular syntheses of the anti-influenza rubrolides R and S

  2019cites this paper
• SAR Exploration of Tight Binding Inhibitors of Influenza Virus PA Endonuclease.

  2019cites this paper
• jmbReview Elucidation of the Inhibitory Mechanisms of Nipponoparmelia laevior Lichen Extract against Influenza A ( H 1 N 1 ) Virus through Proteomic Analyses

  2019cites this paper
• Size and Flexibility Define the Inhibition of the H3N2 Influenza Endonuclease Enzyme by Calix[n]arenes

  2019cites this paper
• Overview of Recent Strategic Advances in Medicinal Chemistry.

  2019cites this paper
• Investigational antiviral therapies for the treatment of influenza

  2019cites this paper
• Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference

  2019cites this paper
• The literature of heterocyclic chemistry, part XVII, 2017

  2019cites this paper
• Elucidation of the Inhibitory Mechanisms of Nipponoparmelia laevior Lichen Extract against Influenza A (H1N1) Virus through Proteomic Analyses

  2019cites this paper
• Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy.

  2019cites this paper
• Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker.

  2019cites this paper
• Interplay between Influenza Virus and the Host RNA Polymerase II Transcriptional Machinery

  2019cites this paper
• Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain

  2019cites this paper
• Non-chelating p-phenylidene-linked bis-imidazoline analogs of known influenza virus endonuclease inhibitors: Synthesis and anti-influenza activity.

  2019cites this paper
• Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017)

  2018cites this paper
• Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.

  2018cites this paper
• Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.

  2018cites this paper
• Bioactive Compounds from Lichens as Promising Biomaterial for the Treatment of Influenza Virus: A Review

  2018influential citation
• Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening.

  2018cites this paper
• Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition

  2018cites this paper
• Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease

  2017cites this paper
• Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease

  2017cites this paper